Nikhil Shah

@pd-perls.bsky.social and I, present the #PDEchange #podcast
#Exercise and #PeritonealDialysis - Not a healthy "hobby", its medical treatment!!
feat: Dr Stephanie Thompson, Dr Clara Bohm, Dr Paul Bennett

CC: @ispd.org @pdi-journal.bsky.social

Spotify - bit.ly/3UbmFLj
Apple - bit.ly/3WSA4d8

A bold guideline from the beginning!

“We suggest that all individuals with hypertension be screened for primary aldosteronism”

Congratulations to Dr. Kailash Jindal on receiving the CSN Distinguished Service Award 2025!

Congratulations to DoM's Dr. Kailash Jindal on receiving the Canadian Society of Nephrology Distinguished Service Award 2025! www.ualberta.ca/.../kailash-....

Thank you for joining us in celebrating #WorldKidneyDay! Your support helps raise awareness about kidney health and the importance of #EarlyDetection. Together, we’re making kidney care a global priority! Let’s keep the momentum going! #AreYourKidneysOK #KidneyHealthMatters

We are celebrating #WorldKidneyDay with our followers to raise awareness about kidney health #AreYourKidneysOK early diagnosis & prevention of kidney failure. Empowering patients for #peritonealdialysis when kidney replacement therapy is needed.
@ispd.org @pd-perls.bsky.social

On the occasion of the #InternationalWomensDay
@pd-perls.bsky.social and I chat with three extraordinary women in #peritonealdialysis on a new special episode of the #PDExchange #podcast
Podcast Link
Spotify - spoti.fi/3DxBOli
Apple - apple.co/3pboqwa

@ispd.org @pdi-journal.bsky.social

NephJC Editorial Internship — NephJC

Announcing the #NephJC internship, @nephjc.bsky.social and @kireports.bsky.social joining forces

www.nephjc.com/intern-app for details and to apply!

#NephSky

📢 New Issue Alert March 2025
@pdi-journal.bsky.social , @ispd.org
🔗 buff.ly/Ode3kIM
Editor In Chief: @pd-perls.bsky.social
Visual Abstract: @edgarvlermamd.bsky.social , @jmteakell.bsky.social
Social Media Ed: @drnikhilshah.bsky.social
#PeritonealDialysis @SageJournals

#Survey for all #CKD and #Dialysis patients to assess and validate a core outcome of #LifeParticipation a @song_initiative project!
Link - redcap.sydney.edu.au/surveys/?s=P...

Requesting all patients to participate in this key core outcome study.

📣 Calling all #CKD patients! Help develop a new tool to measure life participation in chronic kidney disease. Participate in our study by completing a short online questionnaire. Your input matters! Learn more & join: bit.ly/4hSg4zs #CKDResearch #PatientEngagement #dialysis #peritonealdialysis

The webinar will count on expert speakers, including Dr. Arsh Jain (Interventional Nephrologist), Dr. Todd Penner (Surgeon), and Dr. Christopher Morris (Interventional Radiologist). The discussion will be moderated by Dr. Rob Quinn and Dr. Matthew Oliver.

Welcome! You are invited to join the webinar "Patient selection for PD catheter insertion: A discussion with expert operators". After registering, you will receive a confirmation email about joining the webinar. This is the first webinar of a series focused on PD catheter insertion-related issues, as part of the CIHR grant for the North American PD catheter registry.

The North American PD Catheter Registry, with the ISPD and its North American Chapter , organize a webinar focused on Patient Selection for PD Catheter Insertion.

March 6th, 2025 at noon EST (17h GMT).

We invite you to register now by clicking on the following link: https://buff.ly/41nu26O

Figure 1. Search results and study selection.

Frailty and functional decline significantly impact post-KT outcomes: assessing these risk factors can be a predictor of mortality, graft loss and rehospitalization.
@csnscn.bsky.social @cjkhd.bsky.social
#systematicreview #kidneytransplant #NephSky #AskRenal

doi.org/10.1177/2054...

Happy #ValentinesDay from a nephrologist !!
#NephSky 🥰

Celebrating the Women in #PeritonealDialysis on this day of #InternationalDayofWomenandGirlsinScience #WomenInScience @pdi-journal.bsky.social @ispd.org
Podcast Link
Spotify - bit.ly/3iP1kbe
Apple - bit.ly/3WSA4d8

@un.org @unesco.org
@pd-perls.bsky.social

#PDExchange #Podcast
#WomenInNephrology

Celebrating International Women In Science Day (Feb 11) with Joanne Bargman, @edwinabrown-pd.bsky.social and
Ana Figueiredo.

@un.org @who.int
@ispd.org
@pd-perls.bsky.social
@drnikhilshah.bsky.social
Links
Spotify - bit.ly/3iP1kbe
Apple - bit.ly/3WSA4d8

What about #nephjc and #askrenal.

That was quick.

Checking in on #askrenal

Links to the podcast episode.

@pd-perls.bsky.social @ispd.org @pdi-journal.bsky.social

Spotify
buff.ly/40VmMih

Apple
buff.ly/3EiTVvD

@pdi-journal.bsky.social @ispd.org @pd-perls.bsky.social
Original Article - journals.sagepub.com/doi/full/10....
Editorial - @johannmorelle.bsky.social @carloberg.bsky.social journals.sagepub.com/doi/full/10....

VA - @jmteakell.bsky.social

@pdi-journal.bsky.social @ispd.org @pd-perls.bsky.social
Original Article - journals.sagepub.com/doi/full/10....
Editorial - @johannmorelle.bsky.social @carloberg.bsky.social journals.sagepub.com/doi/full/10....

VA - @jmteakell.bsky.social

The ELIXIR Trial and Xylocor Solution: Exploring the Future of Peritoneal Dialysis by The #PDExchange Podcast In the first PD Exchange podcast episode of 2025, Dr. Nikhil Shah and Dr. Jeff Perl introduce a groundbreaking topic—the ELIXIR trial aimed at evaluating Xylocor, an innovative glucose-sparing…

#PDExchange Podcast - New Episode
@pd-perls.bsky.social and @drnikhilshah.bsky.social dive into the groundbreaking ELIXIR trial protocol! Discover the potential of Xylocor, a novel solution for PD that could revolutionize treatment.

Spotify
https://buff.ly/40VmMih

Apple
https://buff.ly/3EiTVvD

Will Xylocore® be the magic ELIXIR for peritoneal dialysis?

@ispd.org @pdi-journal.bsky.social @drnikhilshah.bsky.social @pd-perls.bsky.social @mlambie.bsky.social

Editorial: journals.sagepub.com/eprint/ENYAN...

Original article: journals.sagepub.com/doi/10.1177/...

#NephJC on #BlueSky
Hello. Lurking.
Nikhil Shah from Edmonton, Alberta.
No COI.

Absolutely.

Testing peritoneal dialysis, #peritonealdialysis @ispdmedia.bsky.social

Testing #askrenal and #nephjc

Welcome! You are invited to join a webinar: Migrating from Twiter/X to Bluesky: tips for a smooth transition. After registering, you will receive a confirmation email about joining the webinar. An interactive session to help all ISPD members and other colleagues to successfully migrate from Twitter/X to the new platform Bluesky, including also practical examples and tips for those who alread...

Whether you are:
- new here and still have doubts about how to use BS;
or
- an experienced user willing to share tips with this flourishing community.

Sign up for tomorrow's Webinar on establishing your Bluesky profile and building your #Nephsky community.

📆: Thu Dec 12th, 17h00 GMT
bit.ly/4gamqtc

@zotero.bsky.social is awesome!!!
New version allows you to highlight/ annotate pdfs in the app itself AND the annotations can be exported to a word file!

And it keeps track of RETRACTIONS!!

best citation manager - free! and Notes App! super cool!
#MedSky #NephSky #NephPearls
@retractionwatch.com